Works matching IS 1470269X AND DT 2010 AND VI 10 AND IP 5

Results: 9

Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 5, p. 431, doi. 10.1038/tpj.2009.64

By:

Bellemare, J.;
Rouleau, M.;
Harvey, M.;
Têtu, B.;
Guillemette, C.

Publication type:

Article

Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 5, p. 418, doi. 10.1038/tpj.2009.63

By:

Correia, C. T.;
Almeida, J. P.;
Santos, P. E.;
Sequeira, A. F.;
Marques, C. E.;
Miguel, T. S.;
Abreu, R. L.;
Oliveira, G. G.;
Vicente, A. M.

Publication type:

Article

A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 5, p. 375, doi. 10.1038/tpj.2009.69

By:

Roses, A. D.;
Lutz, M. W.;
Amrine-Madsen, H.;
Saunders, A. M.;
Crenshaw, D. G.;
Sundseth, S. S.;
Huentelman, M. J.;
Welsh-Bohmer, K. A.;
Reiman, E. M.

Publication type:

Article

A multistep validation process of biomarkers for preclinical drug development.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 5, p. 385, doi. 10.1038/tpj.2009.60

By:

Freeman, W. M.;
Bixler, G. V.;
Brucklacher, R. M.;
Lin, C.-M.;
Patel, K. M.;
VanGuilder, H. D.;
LaNoue, K. F.;
Kimball, S. R.;
Barber, A. J.;
Antonetti, D. A.;
Gardner, T. W.;
Bronson, S. K.

Publication type:

Article

Antipsychotic drugs upregulate lipogenic gene expression by disrupting intracellular trafficking of lipoprotein-derived cholesterol.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 5, p. 396, doi. 10.1038/tpj.2009.62

By:

Kristiana, I.;
Sharpe, L. J.;
Catts, V. S.;
Lutze-Mann, L. H.;
Brown, A. J.

Publication type:

Article

Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 5, p. 458, doi. 10.1038/tpj.2010.9

By:

Graziano, F.;
Canestrari, E.;
Loupakis, F.;
Ruzzo, A.;
Galluccio, N.;
Santini, D.;
Rocchi, M.;
Vincenzi, B.;
Salvatore, L.;
Cremolini, C.;
Spoto, C.;
Catalano, V.;
D'Emidio, S.;
Giordani, P.;
Tonini, G.;
Falcone, A.;
Magnani, M.

Publication type:

Article

Weight gain related to treatment with atypical antipsychotics is due to activation of PKC-β.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 5, p. 408, doi. 10.1038/tpj.2009.67

By:

Pavan, C.;
Vindigni, V.;
Michelotto, L.;
Rimessi, A.;
Abatangelo, G.;
Cortivo, R.;
Pinton, P.;
Zavan, B.

Publication type:

Article

Functional analysis of intron 8 and 3′ UTR variable number of tandem repeats of SLC6A3: differential activity of intron 8 variants.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 5, p. 442, doi. 10.1038/tpj.2009.66

By:

Hill, M.;
Anney, R. J. L.;
Gill, M.;
Hawi, Z.

Publication type:

Article

Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 5, p. 448, doi. 10.1038/tpj.2009.68

By:

Choi, S.-H.;
Aid, S.;
Choi, U.;
Bosetti, F.

Publication type:

Article